Relief Therapeutics Holding SA 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
OQB
Relief Therapeutics Holding SA's latest 20-F filing highlights a strategic refocus on rare dermatological disorders, alongside key financial metrics and operational updates for the fiscal year ended December 31, 2023.